Food and Drug Regulations (C.R.C., c. 870)
Full Document:
Regulations are current to 2013-06-10 and last amended on 2013-05-31. Previous Versions
Canadian Standard Drugs
- SOR/80-544, s. 11.
General
C.06.001. In this Division,
(a) solubility and specific gravity shall be determined at 25°C;
(b) tests for identity, quantitative tests for arsenic, lead, copper, zinc, fluorine, and sulphur dioxide, and limit tests shall be made by the official methods; and
(c) determination of physical and chemical constants shall be carried out by acceptable methods.
Conjugated Estrogens
C.06.002. [S]. Conjugated estrogens shall be the drug conjugated estrogens described in The Pharmacopeia of the United States of America, XVIII (1970), except that
(a) the dilute assay preparation A, assay preparations A and B and equilin reagent described therein shall be prepared by official method DO-29, Conjugated Estrogens, October 15, 1981; and
(b) the identification test described therein shall be performed by official method DO-29, Conjugated Estrogens, October 15, 1981.
- SOR/82-429, s. 5.
Conjugated Estrogens for Injection
C.06.003. [S]. Conjugated estrogens for injection shall be the drug conjugated estrogens for injection described in The Pharmacopeia of the United States of America, XVIII (1970), except that
(a) the dilute assay preparation A, assay preparations A and B and equilin reagent described therein shall be prepared by official method DO-29, Conjugated Estrogens, October 15, 1981; and
(b) the identification test described therein shall be performed by official method DO-29, Conjugated Estrogens, October 15, 1981.
- SOR/82-429, s. 6.
- Date modified: